Abortion Surveillance — United States, 2016
Tara C. Jatlaoui(National Center for Chronic Disease Prevention and Health Promotion), Maura K. Whiteman(National Center for Chronic Disease Prevention and Health Promotion), Michele G. Mandel(National Center for Chronic Disease Prevention and Health Promotion), Titilope Oduyebo, Antoinette T. Nguyen(University of Rochester), Emily E. Petersen, Lindsay Eckhaus(Oak Ridge Associated Universities)
Cited by 63
Related Papers
U.S. Medical Eligibility Criteria for Contraceptive Use, 2016
|MMWR Recommendations and Reports|2016|1.5k
Vital Signs: Update on Zika Virus–Associated Birth Defects and Evaluation of All U.S. Infants with Congenital Zika Virus Exposure — U.S. Zika Pregnancy Registry, 2016
|MMWR Morbidity and Mortality Weekly Report|2017|296
U.S. Medical Eligibility Criteria for Contraceptive Use, 2024
|MMWR Recommendations and Reports|2024|195
Abortion Surveillance — United States, 2019
|MMWR Surveillance Summaries|2021|141
Using a Patient Navigator to Improve Postpartum Care in an Urban Women's Health Clinic
|Obstetrics and Gynecology|2017|137